These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36321906)

  • 1. Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study.
    Hoellinger B; Deboscker S; Danion F; Lavigne T; Severac F; Ruch Y; Ursenbach A; Lefebvre N; Boyer P; Hansmann Y
    Microbiol Spectr; 2022 Dec; 10(6):e0186822. PubMed ID: 36321906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of and Risk Factors for Subsequent Carbapenemase-producing Enterobacterales (CPE) Bacteraemia in Rectal CPE Carriers.
    Kang SW; Park S; Kim AR; Han J; Lee J; Seo H; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    Int J Antimicrob Agents; 2023 Nov; 62(5):106959. PubMed ID: 37633425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study.
    Henoun Loukili N; Loquet A; Perrin A; Gaillot O; Bruandet A; Sendid B; Zahar JR; Nseir S
    J Hosp Infect; 2023 May; 135():4-10. PubMed ID: 36871872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Demographic Characteristics of Patients With a New Diagnosis of Carriage or Clinical Infection With Carbapenemase-Producing
    Adar A; Zayyad H; Azrad M; Libai K; Aharon I; Nitzan O; Peretz A
    Front Public Health; 2021; 9():616793. PubMed ID: 33614584
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study.
    Maseda E; Salgado P; Anillo V; Ruiz-Carrascoso G; Gómez-Gil R; Martín-Funke C; Gimenez MJ; Granizo JJ; Aguilar L; Gilsanz F
    Enferm Infecc Microbiol Clin; 2017; 35(6):333-337. PubMed ID: 27016135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY).
    De La Villa S; Sánchez-Carrillo C; Sánchez-Martínez C; Cercenado E; Padilla B; Álvarez-Uría A; Aguilera-Alonso D; Bermejo E; Ramos R; Alcalá L; Marín M; Valerio M; Urbina L; Muñoz P
    J Antimicrob Chemother; 2023 Aug; 78(8):1948-1954. PubMed ID: 37325878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
    Dickstein Y; Solter E; Schwartz D; Nutman A; Harevrich I; Wulffhart L; Carmeli Y; Schwaber MJ
    Clin Microbiol Infect; 2021 Oct; 27(10):1518.e1-1518.e3. PubMed ID: 34111587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of enhanced screening for carbapenemase-producing Enterobacterales in an acute care hospital in South Korea.
    Park SH; Yi Y; Suh W; Ji SK; Han E; Shin S
    Antimicrob Resist Infect Control; 2023 Jul; 12(1):62. PubMed ID: 37400884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia with Carbapenemase-Producing
    Averbuch D; Moshkovitz L; Ilan S; Abu Ahmad W; Temper V; Strahilevitz J
    Microb Drug Resist; 2022 May; 28(5):593-600. PubMed ID: 35580283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review.
    Bar Ilan M; Kjerulf A
    J Hosp Infect; 2023 Dec; 142():74-87. PubMed ID: 37802236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
    Daroukh A; Delaunay C; Bigot S; Ceci JM; Siddhoun N; Bukreyeva I; Raisin J; Porcheret H; Maisonneuve L; Bouldouyre MA
    Med Mal Infect; 2014 Jul; 44(7):321-6. PubMed ID: 25022890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.
    Gutiérrez-Gutiérrez B; Salamanca E; de Cueto M; Hsueh PR; Viale P; Paño-Pardo JR; Venditti M; Tumbarello M; Daikos G; Cantón R; Doi Y; Tuon FF; Karaiskos I; Pérez-Nadales E; Schwaber MJ; Azap ÖK; Souli M; Roilides E; Pournaras S; Akova M; Pérez F; Bermejo J; Oliver A; Almela M; Lowman W; Almirante B; Bonomo RA; Carmeli Y; Paterson DL; Pascual A; Rodríguez-Baño J;
    Lancet Infect Dis; 2017 Jul; 17(7):726-734. PubMed ID: 28442293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit of Amizour Hospital, Algeria: A Prospective Cohort Study.
    Touati A; Talbi M; Mairi A; Messis A; Adjebli A; Louardiane M; Lavigne JP
    Microb Drug Resist; 2020 Nov; 26(11):1383-1389. PubMed ID: 32181693
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area.
    Papafotiou C; Roussos S; Sypsa V; Bampali S; Spyridopoulou K; Karapanou A; Moussouli A; Samarkos M; Daikos GL; Psichogiou M
    J Antimicrob Chemother; 2022 Nov; 77(12):3331-3339. PubMed ID: 36203392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis.
    Ortiz-Brizuela E; Caro-Vega Y; Bobadilla-Del-Valle M; Leal-Vega F; Criollo-Mora E; López Luis BA; Esteban-Kenel V; Torres-Veintimilla E; Galindo-Fraga A; Olivas-Martínez A; Tovar-Calderón E; Torres-González P; Sifuentes-Osornio J; Ponce-de-León A
    J Hosp Infect; 2020 Aug; 105(4):757-765. PubMed ID: 32565368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.